LivaNova (LIVN) Income from Non-Controlling Interests (2017)
LivaNova (LIVN) reported Income from Non-Controlling Interests of $1.9 million for Q4 2017, up 334.82% sequentially from -$830000.0 in Q3 2017.
LivaNova (LIVN) Income from Non-Controlling Interests (2017) Analysis & Trends
LivaNova (LIVN) has 1 years of Income from Non-Controlling Interests data on file, last reported at $1.9 million in Q4 2017.
- For the quarter ending Q4 2017, Income from Non-Controlling Interests changed N/A year-over-year to $1.9 million; the trailing twelve-month figure through Dec 2017 stood at $1.3 million (changed N/A YoY), and the FY2017 full-year result was $1.3 million, down 98.03% from the prior year.
- Income from Non-Controlling Interests improved to $1.9 million in Q4 2017, from -$830000.0 in the prior quarter.
- In the past five years, Income from Non-Controlling Interests ranged from a high of $2.0 million in Q1 2017 to a low of -$1.8 million in Q2 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 16.00 Mn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 22.00 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | -5.85 Mn |
| 10 | LivaNova | 4.40 Bn | 3.86 Bn | 243.75 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 1.95 Mn |
| Sep 30, 2017 | -830,000.00 |
| Jun 30, 2017 | -1.80 Mn |
| Mar 31, 2017 | 1.96 Mn |